Ernexa Therapeutics Inc. Warrants (NASDAQ: ERNAW) last traded at $0.0280, down 6.67% on the session. The quote above updates while this page is open; the figures below are drawn from Ernexa Therapeutics Inc. Warrants’s own filings and are restated only when a new one is published.
Ernexa Therapeutics Inc. Warrants trades on NASDAQ under the ticker ERNAW. Its market capitalisation is $45,707.508.
Valuation measures for Ernexa Therapeutics Inc. Warrants, derived from the latest quote and its most recent SEC filing.
| Market cap | $45.7K |
|---|---|
| Enterprise value | -$1.15M |
| Price / book | 0.01 |
Trailing-twelve-month figures tagged in Ernexa Therapeutics Inc. Warrants's XBRL filings with the SEC.
| Net income (TTM) | -$12.26M |
|---|---|
| Return on equity |
|---|
| -383.06% |
| Cash | $4.32M |
|---|
Range and volume for ERNAW over the past 52 weeks.
| 52-week high | $0.0310 |
|---|---|
| 52-week low | $0.0250 |
| Volume | 14.9K |
| Average volume | 14.9K |
| Previous close | $0.0300 |
Invest a chosen dollar amount in Ernexa Therapeutics Inc. Warrants with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ERNAW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.